학술논문
Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Document Type
Article
Author
Source
In Value in Health September 2015 18(6):876-883
Subject
Language
ISSN
1098-3015